CA
NZ
UK
AU
IND
US
Splash Beverage Group (NYSE American: SBEV) jumped 28.72% to $0.31 on June 4, extending a sharp speculative move after the company provided an update on its NYSE American compliance process and strategic transaction initiatives.
The Oncology Institute (Nasdaq:TOI) rose 11.94% to $4.74 in intraday trading on June 4, as of the latest available update. The move came after the stock opened near $4.24 and traded within a day range of $4.23 to $4.77, suggesting a sharp improvement inDemandduring …
UnitedHealth Group (NYSE:UNH) rose 5.24% to $396.77 in intraday trading on June 4, as of the latest available update. The stock moved closer to its 52-week high of $404.15 as investors responded to a stronger analyst backdrop and renewed confidence in the healthcare giant’sEarningsoutlook.
Oscar Health (NYSE: OSCR) surged 12.93% to $23.15 on June 4, as investors reacted to a Wells Fargo upgrade that improved sentiment around the healthcare insurer’s operating outlook. The brokerage raised its rating to Equalweight from Underweight and increased its price target to $20 …
Personalis (Nasdaq: PSNL) rose 14.93% to $12.39 in intraday trading on June 4, as of the latest available update. The stock moved close to its 52-week high after investors responded to clinical data presented at the 2026 American Society of Clinical Oncology Annual Meeting.
Sera Prognostics (Nasdaq: SERA) rose 7.56% to $2.21 on June 4, as investors responded to improving sentiment around its commercial strategy and reimbursement outlook. The move followed fresh attention on the company’s presentation at the Jefferies Global Healthcare Conference, where management highlighted its shift …
BillionToOne (Nasdaq:BLLN) rose 9.67% to $107.87 in intraday trading on June 4, as of the latest available update. The move came after the company presented at the 46th Annual William Blair Growth Stock Conference on June 2, where management highlighted the strength of its …
Humana (NYSE: HUM) rose 6.42% to $348.56 in intraday trading on June 4, as of the latest available update. The move pushed the stock close to its 52-week high, reflecting a broader improvement in investor appetite for managed care companies.
INVO Fertility Rises on Growth and Balance-Sheet Signals
NewGenIvf Group (Nasdaq: NIVF) rose 5.88% to $0.89 in intraday trading on June 4, as of the latest available update, after the company announced a deeper investment in K25.ai and adopted a digital asset treasury strategy.
Please wait processing your request...